EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Treatment Intensification Prior to Radical Prostatectomy for Clinically Localized Prostate Cancer

Carlos Jesus Perez Kerkvliet, Joon Yau Leong, Rasheed A M Thompson iD, Kevin Kayvan Zarrabi, William Kevin Kelly iD, Costas Lallas, Leonard Gomella, Mihir Shah iD

Cancers · 07.07.2025 · 17 (13) · 2258

DOI: 10.3390/cancers17132258 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 07.07.2025. Verfasst von Carlos Jesus Perez Kerkvliet und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Sidney Kimmel Cancer Center, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current guidelines recommend either radical prostatectomy (RP) or radiation with androgen deprivation therapy (ADT) for unfavorable intermediate- or high-risk prostate cancer. There has been emerging interest in the potential benefits of neoadjuvant ADT prior to RP for this population. Past trials indicate neoadjuvant ADT may be associated with reduced surgical complexity, pathologic downstaging, decreased positive margins, and decreased rates of nodal positivity, although they have not shown benefits for cancer progression and survival. Accordingly, neoadjuvant ADT is currently not recommended for surgical patients. Conversely, ADT is a mainstay of treatment in metastatic disease, and interest remains in expanding its use towards patients with clinically localized disease. There are several ongoing trials of second-generation androgen blockers such as enzalutamide, darolutamide, radiopharmaceuticals, and poly (ADP-ribose) polymerase (PARP) inhibitors to explore long-term cancer-specific survival benefits with neoadjuvant use. In this narrative review, we provide a comprehensive overview of the recent literature and ongoing efforts to incorporate neoadjuvant therapy for clinically localized prostate cancer patients who are at high-risk of recurrence after prostatectomy.

Schlagwörter

Stichwörter der Autor:innen

cancerchemotherapyneoadjuvantprostateprostatectomy

Autor:innen und Institutionen

  • Department of Urology, Sidney Kimmel Cancer Center, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.
  • Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University Hospital, Philadelphia, PA 10107, USA.

ORCID-Profile: Rasheed A M Thompson, William Kevin Kelly, Mihir Shah

Zitieren

APA

Perez Kerkvliet, C. J., Leong, J. Y., Thompson, R. A. M., Zarrabi, K. K., Kelly, W. K., Lallas, C., Gomella, L., & Shah, M. (2025). Treatment Intensification Prior to Radical Prostatectomy for Clinically Localized Prostate Cancer. Cancers, 17(13), 2258. https://doi.org/10.3390/cancers17132258

Vancouver

Perez Kerkvliet CJ, Leong JY, Thompson RAM, Zarrabi KK, Kelly WK, Lallas C, et al. Treatment Intensification Prior to Radical Prostatectomy for Clinically Localized Prostate Cancer. Cancers. 2025;17(13):2258. doi:10.3390/cancers17132258

BibTeX
@article{PerezKerkvliet2025,
  author = {Perez Kerkvliet, Carlos Jesus and Leong, Joon Yau and Thompson, Rasheed A M and Zarrabi, Kevin Kayvan and Kelly, William Kevin and Lallas, Costas and Gomella, Leonard and Shah, Mihir},
  title = {Treatment Intensification Prior to Radical Prostatectomy for Clinically Localized Prostate Cancer},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {13},
  pages = {2258},
  doi = {10.3390/cancers17132258}
}
Kostenlos starten →